Form 483

Medico Labs, Inc. Form 483, 2008-10-30

FDA issued a Form 483 to Medico Labs, Inc. on 2008-10-30 with 9 public-safe observations.

483· Form 483 issued9 observations

Medico Labs, Inc. · Trenton, United States · Issued October 30, 2008

Overview

  • 9 public-safe observations are available for this inspection.
  • 8 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

30 Oct 2008
21 CFR 211.22(a)

Authority lacking to review records, investigate errors

Cited by Annemarie Bodnar, Daniel J Grabicki

30 Oct 2008
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Annemarie Bodnar, Daniel J Grabicki

30 Oct 2008
21 CFR 211.84(d)(2)

Reports of Analysis (Components)

Cited by Annemarie Bodnar, Daniel J Grabicki

30 Oct 2008
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Annemarie Bodnar, Daniel J Grabicki

30 Oct 2008
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Annemarie Bodnar, Daniel J Grabicki

Inspected site

MLMedico Labs, Inc.Trenton, United States

Inspection team

DJDaniel J Grabicki

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.192Cited across public-safe Form 483 observations2x
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.165(f)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(2)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 9 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere